Children with cancer are missing out on precision medicine, study finds

24 September 2019 - Only a small number of children with solid tumour cancers are able to access targeted precision ...

Read more →

Personalised medicine and pay for performance: should pharmaceutical firms be fully penalised when treatment fails?

17 June 2018 - In this article, we model the behaviour of a pharmaceutical firm that has marketing authorisation for a ...

Read more →